Article
Concise Review: Updated Advances and Current Challenges in Cell Therapy for Inborn Liver Metabolic Defects.
Stem cells translational medicine - 1 Aug 2016
Najimi Mustapha, Defresne Florence, Sokal Etienne M
Abstract excerpt
UNLABELLED: : The development of liver cell transplantation (LCT), considered a major biotechnological breakthrough, was intended to provide more accessible treatments for liver disease patients. By preserving the native recipient liver and decreasing hospitalization time, this innovative approach has progressively gained interest among clinicians. LCT initially targets inborn errors of liver metabolism, enabling...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
